HDL causes mesangial cell mitogenesis through a tyrosine kinase-dependent receptor mechanism

Journal of the American Society of Nephrology

Volumn 8, Issue 8, 1997, Pages 1247-1256

  Neverov, Nikita I ^a,d   Kaysen, George A ^a,c   Nuccitelli, Richard ^b   Weiss, Robert H ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

HERBIMYCIN A; HIGH DENSITY LIPOPROTEIN; RECOMBINANT HUMAN INSULIN; SPHINGOMYELIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLOMERULOSCLEROSIS; IMMUNOBLOTTING; MALE; MESANGIUM CELL; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

EID: 0030732431     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Schmitz PG, Kasiske BL, O'Donnell MP, Keane WF: Lipids and progressive renal injury. Semin Nephrol 9: 354-369, 1989
2. Wellman KF, Volk BW: Renal changes in experimental hypercholesterolemia in normal and subdiabetic rabbits. I. Short term studies. Lab Invest 22: 36-48, 1970
3. Drevon CA, Hoving T: The effects of cholesterol/fat feeding on lipid levels and morphological structures in liver, kidney and spleen in guinea pigs. Acta Pathol Microbiol Immunol Scand 85: 1-18, 1977
4. Al-Shebeb T, Frohlich J, Magil AB: Glomerular disease in hypercholesterolemic guinea pigs: A pathogenetic study. Kidney Int 33: 498-507, 1988
5. Kasiske BL, O'Donnell MP, Cleary MP, Keane WF: Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 33: 667-672, 1988
6. Hara S, Arizono K, Ubara Y, Morita T, Suzuki Y, Ogura Y, Hagura R, Akanuma Y: Risk factors for retardation of renal function in IDDM and NIDDM with nephropathy. J Diabetic Complications 5: 131-133, 1991
7. Lam KS, Cheng IK, Janus ED, Pang RW: Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia 38: 604-609, 1995
8. Neugarten J, Schlondorff D: Lipoprotein interactions with glomerular cells and matrix. Contemporary Issues in Nephrology 24: 173-206, 1991, Keane WF, Stein JH ed. Churchill Livingstone NY
9. Rayner HC, Horsburgh T, Brown SL, Lavender FL, Winder AF, Walls J: Receptor-mediated endocytosis of low-density lipoprotein by cultured human glomerular cells. Nephron 55: 292-299, 1990
10. Kaysen GA, Hoye E, Jones H Jr, van Toi A, Joles JA: Effect of oncotic pressure on apolipoprotein A-I metabolism in the rat. Am J Kidney Dis 26: 178-186, 1995
11. Marshall JF, Apostolopoulos JJ, Brack CM, Howlett GL: Regulation of apolipoprotein gene expression and plasma high-density lipoprotein composition in experimental nephrosis. Biochim Biophys Acta 1042: 271-279, 1990
12. Kaysen GA, Hoye E, Jones H Jr: Apolipoprotein AI levels are increased in part as a consequence of reduced catabolism in nephrotic rats. Am J Physiol 268: F532-F540, 1995
13. Voyno-Yasenetskaya TA, Dobbs LG, Erickson SK, Hamilton RL: Low density lipoprotein- and high density lipoprotein-mediated signal transduction and exocytosis in alveolar type II cells. Proc Natl Acad Sci USA 90: 4256-4260, 1993
14. Yagi K: A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 15: 212-216, 1976
15. Curry MD, Gustafson A, Alaupovic P, McConathy WJ: Electroimmunoassay, radioimmunoassay, and radial immunodiffusion assay evaluated for quantification of human apolipoprotein B. Clin Chem 24: 280-286, 1978
16. Sun X, Jones H, Joles JA, van Tol A, Kaysen GA: Apolipoprotein gene expression in analbuminemic rats and in rats with Heymann nephritis. Am J Physiol 262: F755-F761, 1992
17. Brinton EA, Oram JF, Chen CH, Albers JJ, Bierman EL: Binding of high density lipoprotein to cultured fibroblasts after chemical alteration of apoprotein amino acid residues. J Biol Chem 261: 495-503, 1986
18. Weiss RH, Huang C-L, Ives HE: Sphingosine reverses growth inhibition caused by activation of protein kinase C in vascular smooth muscle cells. J Cell Physiol 149: 307-312, 1991
19. Weiss RH, Nuccitelli R: Inhibition of tyrosine phosphorylation prevents thrombin-induced mitogenesis, but not intracellular free calcium release, in vascular smooth muscle cells. J Biol Chem 267: 5608-5613, 1992
20. Ullian ME, Hutchison FN, Hazen-Martin DJ, Morinelli TA: Angiotensin II-aldosterone interactions on protein synthesis in vascular smooth muscle cells. Am J Physiol 264: C1525-C1531, 1993
21. Tsien RY, Harootunian AT: Practical design criteria for a dynamic ratio imaging system. Cell Calcium 11: 93-109, 1990
22. Poenie M: Alteration of intracellular Fura-2 fluorescence by viscosity: A simple correction. Cell Calcium 11: 85-91, 1990
23. Sachinidis A, Locher R, Vetter W, Tatje D, Hoppe J: Different effects of platelet-derived growth factor isoforms on rat vascular smooth muscle cells. J Biol Chem 265: 10238-10243, 1990
24. Ullrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203-212, 1990
25. Eisenberg S: Lipoproteins and lipoprotein metabolism. A dynamic evaluation of the plasma fat transport system. Klin Wochenschr 61: 119-132, 1983
26. Steinberg D: A docking receptor for HDL cholesterol esters. Science 271: 460-461, 1996
27. Glass CK, Pittman RC, Keller GA, Steinberg D: Tissue sites of degradation of apoprotein A-I in the rat. J Biol Chem 258: 7161-7167, 1983
28. Gherardi E, Calandra S: Plasma and urinary lipids and lipoproteins during the development of nephrotic syndrome induced in the rat by puromycin aminonucleoside. Biochim Biophys Acta 710: 188-196, 1981
29. Shore VG, Forte T, Licht H, Lewis SB: Serum and urinary lipoproteins in the human nephrotic syndrome: Evidence for renal catabolism of lipoproteins. Metabolism 31: 258-268, 1982
30. Bochkov VN, Tkachuk VA, Kuzmenko YS, Borisova YL, Buhler FR, Resnik TJ: Characteristics of low and high density lipoprotein binding and lipoprotein-induced signaling in quiescent human vascular smooth muscle cells. Mol Pharmacol 45: 262-270, 1994
31. Wheeler D, Persaud JW, Fernando R, Sweny P, Varghese Z, Moorhead JF: Effects of low-density lipoproteins on mesangial cell growth and viability in vitro. Nephrol Dial Transplant 5: 185-191, 1990
32. Kim SB, Kang SA, Cho YJ, Park SK, Cheong HI, Lee JD, Hong CD, Park JS: Effects of low density lipoprotein on type IV collagen production by cultured rat mesangial cells. Nephron 67: 327-333, 1994
33. Kazama Y, Noguchi T, Kanemaru Y, Wakasugi M, Onaya T, Yoshida Y: Effect of insulin on the production of prostacyclin and cell proliferation in cultured smooth muscle cells. Prostaglandins Leukotrienes Essent Fatty Acids 37: 129-134, 1989
34. Frank HJL, Levin ER, Hu R-M, Pedram A: Insulin stimulates endothelin binding and action on cultured vascular smooth muscle cells. Endocrinology 133: 1092-1097, 1993
35. Conti FG, Striker LJ, Lesniak MA, MacKay K, Roth J, Striker GE: Studies on the binding and mitogenic effect of insulin and insulin-like growth factor I in glomerular mesangial cells. Endocrinology 122: 2788-2795, 1988
36. Weiss RH, Maduri M: The mitogenic effect of thrombin in vascular smooth muscle cells is largely due to basic fibroblast growth factor. J Biol Chem 268: 5724-5727, 1993
37. --induced phosphoinositide breakdown in hamster fibroblasts. J Biol Chem 263: 12893-12900, 1988
38. 2+ in cultured fibroblasts. Biochem J 279: 29-33, 1991
39. Bochkov V, Tkachuk V, Buhler F, Resink T: Phosphoinositide and calcium signaling responses in smooth muscle cells: Comparison between lipoproteins, ang II and PDGF. Biochem Biophys Res Commun 188: 1295-1304, 1988
40. 2+-dependent phosphorylation of a 20 kDa protein in the proliferative effect of high-density lipoproteins (subclass 3) on the adenocarcinoma cell line A549. Biochem J 307: 557-561, 1995
41. Song JH, Varghese Z, Moorhead JF: HDL stimulates tubular ET-1 production through protein tyrosine kinase dependent pathway [Abstract]. J Am Soc Nephrol 6: 812, 1995
42. Mendez AJ, Oram JF, Bierman EL: Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J Biol Chem 166: 10104-10111, 1991
43. Theret N, Delbart C, Aguie G, Fruchart JC, Vassaux G, Ailhaud G: Cholesterol efflux from adipose cells is coupled to diacylglycerol production and protein kinase C activation. Biochem Biophys Res Commun 173: 1361-1368, 1990